Background and purpose: The European Federation of Neurological Associations (EFNA), in partnership with the NeuroCOVID-19 taskforce of the European Academy of Neurology (EAN), has investigated the impact of the first wave of the COVID-19 pandemic on individuals with neurological diseases, as well as the hopes and fears of these patients about the post-pandemic phase. Methods: An EFNA-EAN survey was available online to any person living with a neurological disorder in Europe. It consisted of 18 items concerning the impact of the first wave of the COVID-19 pandemic on the medical care of people with neurological disorders, and the hopes and fears of these individuals regarding the post-pandemic phase. Results: For 44.4% of the 443 survey participants, the overall care of their neurological disease during the pandemic was inappropriate. This perception was mainly due to significant delays in accessing medical care (25.7%), insufficiently reliable information received about the potential impact of COVID-19 on their neurological disease (49.6%), and a substantial lack of involvement in their disease management decisions (54.3%). Participants indicated that their major concerns for the post-pandemic phase were experiencing longer waiting times to see a specialist (24.1%), suffering from social isolation and deteriorating mental well-being (23.1%), and facing delays in clinical trials with disinvestment in neuroscience research (13.1%). Conclusions: Despite the great efforts of health services to cope with the first wave of the COVID-19 pandemic, individuals with neurological conditions feel they have been left behind. These findings provide invaluable insights for improving the care of patients with neurological disorders in the further course of the COVID-19 pandemic.

Lessons learned from people with neurological diseases at the time of COVID-19: The EFNA-EAN survey / B. Bodini, E. Moro, J. Jaarsma, E. Cunningham, J. Sellner, D. Walsh, C.L. Bassetti, E. Beghi, D. Bereczki, B. Bodini, A. Burlica, F. Cavallieri, M. Crean, G. Di Liberto, R. Helbok, T.M. Jenkins, A. Macerollo, L.F. Maia, E. Moro, C. Oreja-Guevara, S. Ozturk, M. Rakusa, A. Sauerbier, J. Sellner, R. Soffietti, P. Taba, A. Pisani, A. Priori, T.J. von Oertzen, M. Zedde. - In: EUROPEAN JOURNAL OF NEUROLOGY. - ISSN 1351-5101. - 29:1(2022 Jan), pp. 318-323. [10.1111/ene.15087]

Lessons learned from people with neurological diseases at the time of COVID-19: The EFNA-EAN survey

B. Bodini;G. Di Liberto;A. Macerollo;A. Priori;
2022

Abstract

Background and purpose: The European Federation of Neurological Associations (EFNA), in partnership with the NeuroCOVID-19 taskforce of the European Academy of Neurology (EAN), has investigated the impact of the first wave of the COVID-19 pandemic on individuals with neurological diseases, as well as the hopes and fears of these patients about the post-pandemic phase. Methods: An EFNA-EAN survey was available online to any person living with a neurological disorder in Europe. It consisted of 18 items concerning the impact of the first wave of the COVID-19 pandemic on the medical care of people with neurological disorders, and the hopes and fears of these individuals regarding the post-pandemic phase. Results: For 44.4% of the 443 survey participants, the overall care of their neurological disease during the pandemic was inappropriate. This perception was mainly due to significant delays in accessing medical care (25.7%), insufficiently reliable information received about the potential impact of COVID-19 on their neurological disease (49.6%), and a substantial lack of involvement in their disease management decisions (54.3%). Participants indicated that their major concerns for the post-pandemic phase were experiencing longer waiting times to see a specialist (24.1%), suffering from social isolation and deteriorating mental well-being (23.1%), and facing delays in clinical trials with disinvestment in neuroscience research (13.1%). Conclusions: Despite the great efforts of health services to cope with the first wave of the COVID-19 pandemic, individuals with neurological conditions feel they have been left behind. These findings provide invaluable insights for improving the care of patients with neurological disorders in the further course of the COVID-19 pandemic.
chronic disorders; COVID-19; medical care; neurology; people with neurological disease; perspective; survey; Humans; Pandemics; SARS-CoV-2; Surveys and Questionnaires; COVID-19; Nervous System Diseases
Settore MED/26 - Neurologia
30-ago-2021
Article (author)
File in questo prodotto:
File Dimensione Formato  
ene.15087.pdf

embargo fino al 01/01/2023

Tipologia: Post-print, accepted manuscript ecc. (versione accettata dall'editore)
Dimensione 7.19 MB
Formato Adobe PDF
7.19 MB Adobe PDF   Visualizza/Apri   Richiedi una copia
Euro J of Neurology - 2021 - Bodini - Lessons learned from people with neurological diseases at the time of COVID‐19 The.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 216.14 kB
Formato Adobe PDF
216.14 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/896752
Citazioni
  • ???jsp.display-item.citation.pmc??? 2
  • Scopus 2
  • ???jsp.display-item.citation.isi??? 1
social impact